MIRA INFORM REPORT

Report Date :

11.07.2012

IDENTIFICATION DETAILS

Name :	SYMED LABORATORIES LIMITED
Formerly Known As :	SYMED LABS PRIVATE LIMITED
Registered Office :	8-3-166/6, 2^nd Floor Sree Arcade, Erragadda, Hyderabad – 500 018, Andhra Pradesh
Country :	India
Financials (as on) :	31.03.2011
Date of Incorporation :	17.08.1998
Com. Reg. No.:	01–029961
Capital Investment / Paid-up Capital :	Rs. 9.301 Millions
CIN No.: [Company Identification No.]	U24231AP1998PLC029961
TAN No.: [Tax Deduction & Collection Account No.]	HYDS03532E
PAN No.: [Permanent Account No.]	AADCS5186M
Legal Form :	A Closely held Public Limited Liability Company
Line of Business :	Manufactures of Bulk Drugs and Drug Intermediates
No. of Employees :	205 (In office 15 + In factory 190)

RATING & COMMENTS

MIRA’s Rating :

Ba (53)

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Maximum Credit Limit :	USD 3400000
Status :	Good
Payment Behaviour :	Regular
Litigation :	Clear
Comments :	Subject is a well established company having fine track. Financial position of the company appears to be strong. Trade relations are reported as decent. Business is active. Payments are reported to be regular and as per commitments. The company can be considered good for business dealings at usual trade terms and conditions.

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – September 30, 2011

Country Name	Previous Rating (30.09.2011)	Current Rating (31.12.2011)
India	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

LOCATIONS

Registered Office :	8-3-166/6, 2^nd Floor Sree Arcade, Erragadda, Hyderabad – 500 018, Andhra Pradesh, India
Tel. No.:	91-40-23708103 / 23812650 / 23704923 / 24
Fax No.:	91-40-23708103
E-Mail :	info@symedlabs.com dmohanrao@symedlabsltd.com ramu@heterdrugs.com vasucs@heterodrugs.com accounts@symedlabs.com
Website :	www.symedlabs.com

DIRECTORS

AS ON 29.09.2011

Name :

Dr. Mohana Rao Dodda

Designation :

Managing director

Address :

H. No.21, Madhuranagar Colony, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

11.04.1958

Date of Appointment :

01.04.1999

DIN No.:

00126836

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Company/ LLP Status	Defaulting status
1	U24231AP1998PLC029961	SYMED LABS LIMITED	Managing director	01/04/2009	01/04/1999	Active	NO
2	U70102AP2005PTC048210	HETSYM ESTATES AND REALTORS PRIVATE LIMITED	Director	29/11/2005	29/11/2005	Active	NO
3	U21023AP2007PTC054088	CHEMI PACK (INDIA) PRIVATE LIMITED	Director	29/05/2007	29/05/2007	Active	NO
4	U24110AP2008PTC058116	SYMED CHEMICALS PRIVATE LIMITED	Director	11/03/2008	11/03/2008	Active	NO
5	U73100AP2008PTC058109	HETSYM BIO CHEMICALS PRIVATE LIMITED	Director	11/03/2008	11/03/2008	Active	NO
6	U40108AP2011PTC077815	SRI CHENNA KESAVA BIO ENERGY PRIVATE LIMITED	Director	05/12/2011	05/12/2011	Active	NO

Name :

Dr. Bandi Partha Saradhi Reddy

Designation :

Director

Address :

Plot No.389, Road No.22/B, Jubliee Hills Check-post, Hyderabad – 500 033, Andhra Pradesh, India

Date of Birth/Age :

06.08.1954

Date of Appointment :

10.08.2000

DIN No.:

00015899

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U65993AP1993PTC015489	BANDIS INVESTMENTS PRIVATE LIMITED	Director	12/03/1993	12/03/1993	-	Active	NO
2	U24230AP1993PLC015582	HETERO DRUGS LIMITED	Managing director	01/04/2008	07/04/1993	-	Active	NO
3	U24110AP1989PLC009723	HETERO LABS LIMITED	Managing director	01/11/2011	05/12/1996	-	Active	NO
4	U72200AP1997PTC027306	HETERO MARBLES PRIVATE LIMITED	Director	12/06/1997	12/06/1997	-	Active	NO
5	U24239AP1990PLC012119	CIREX PHARMACEUTICALS LIMITED	Director	01/04/2000	01/04/2000	-	Active	NO
6	U24231AP1998PLC029961	SYMED LABS LIMITED	Director	31/03/2009	10/08/2000	-	Active	NO
7	U24239AP1995PLC020625	SAKETHA DRUGS AND INTERMEDIATES LIMITED	Director	18/04/2001	18/04/2001	-	Active	NO
8	U24239AP2002PLC040108	HETERO INTERNATIONAL LIMITED	Director	16/12/2002	16/12/2002	21/04/2011	Active	NO
9	U24239AP2004PLC043684	HETERO BIOTECH LIMITED	Director	19/07/2004	19/07/2004	29/06/2011	Active	NO
10	U24239AP2004PTC044633	INVAGEN PHARMACEUTICALS PRIVATE LIMITED	Director	17/11/2004	17/11/2004	-	Active	NO
11	U24230AP2004PTC044710	XIVA HEALLTH CARE PRIVATE LIMITED	Director	29/11/2004	29/11/2004	30/08/2011	Active	NO
12	U24239AP2005PTC046555	EXPICOR PHARMA PRIVATE LIMITED	Director	16/06/2005	16/06/2005	01/12/2010	Active	NO
13	U70102AP2005PTC048210	HETSYM ESTATES AND REALTORS PRIVATE LIMITED	Director	29/11/2005	29/11/2005	-	Active	NO
14	U45200AP2006PLC049668	HETERO INFRASTRUCTURE SEZ LIMITED	Director	31/03/2006	31/03/2006	-	Active	NO
15	U73100AP2007PTC052262	HETERO LIFE SCIENCES PRIVATE LIMITED	Director	05/01/2007	05/01/2007	-	Active	NO
16	U24239AP1996PLC025371	GENX PHARMA LIMITED	Director	26/09/2007	26/07/2007	-	Active	NO
17	U72900AP2007PLC055111	HETERO INFORMATION TECHNOLOGIES LIMITED	Director	10/08/2007	10/08/2007	-	Active	NO
18	U45400AP2007PTC055329	SAI SPURTHI LAND VENTURES PRIVATE LIMITED	Director	30/08/2007	30/08/2007	-	Active	NO
19	U01119AP2007PTC055326	SRI SANKARANATH AGRITECH PRIVATE LIMITED	Director	30/08/2007	30/08/2007	-	Active	NO
20	U45400AP2007PTC055324	SRI AYYAPPA LAND HOLDINGS PRIVATE LIMITED	Director	30/08/2007	30/08/2007	-	Active	NO
21	U45200AP2007PTC055523	SRI LORD VENKATESWARA LAND HOLDINGS PRIVATE LIMITED	Director	14/09/2007	14/09/2007	-	Active	NO
22	U01119AP2007PTC055650	RAJESWARI AGRO CHEMICALS PRIVATE LIMITED	Director	22/09/2007	22/09/2007	-	Active	NO
23	U72200AP2007PLC055910	HETERO MED SOLUTIONS LIMITED	Director	15/10/2007	15/10/2007	-	Active	NO
24	U74999AP2007PLC056072	SRI SAI ASHIRWAAD LOGISTICS LIMITED	Director	25/10/2007	25/10/2007	-	Active	NO
25	U72200AP2008PTC057903	SRI SHIVA SHANKAR SOFT SERVICES PRIVATE LIMITED	Director	28/02/2008	28/02/2008	-	Active	NO
26	U70102AP2008PTC057902	SHREE SHIVA SINDHU REAL ESTATES PRIVATE LIMITED	Director	28/02/2008	28/02/2008	-	Active	NO
27	U01119AP2008PTC057982	LAKSHMI PRASANNA AGRI PRODUCTS PRIVATE LIMITED	Director	05/03/2008	05/03/2008	-	Active	NO
28	U74900AP2008PLC058017	SHRI BHRAMARAMBIKAS INDUSTRYS LIMITED	Director	06/03/2008	06/03/2008	-	Active	NO
29	U24299AP2008PLC058020	HETERO BIO CHEMICALS LIMITED	Director	06/03/2008	06/03/2008	29/06/2011	Active	NO
30	U24110AP2008PTC058116	SYMED CHEMICALS PRIVATE LIMITED	Director	11/03/2008	11/03/2008	-	Active	NO
31	U73100AP2008PTC058109	HETSYM BIO CHEMICALS PRIVATE LIMITED	Director	11/03/2008	11/03/2008	-	Active	NO
32	U70102AP2008PTC058106	SRI SHAKTI SWAROOPINI REALTORS PRIVATE LIMITED	Director	11/03/2008	11/03/2008	-	Active	NO
33	U45209AP2008PTC059000	SREE SAI KHYATHI INFRA VENTURES PRIVATE LIMITED	Director	05/05/2008	05/05/2008	-	Active	NO
34	U45200AP2008PTC059007	SHREE SAI LOK AVENUES PRIVATE LIMITED	Director	06/05/2008	06/05/2008	-	Active	NO
35	U52520AP2006PLC049614	HETERO HEALTHCARE LIMITED	Director	24/09/2009	01/10/2008	-	Active	NO
36	U24230AP1984PTC004422	SVS DRUGS AND PHARMACEUTICALS PVT LTD	Director	19/08/2010	12/11/2009	-	Active	NO
37	U40100AP2010PLC071837	HETERO WIND POWER LIMITED	Director	23/12/2010	23/12/2010	-	Active	NO
38	U24232AP2011PLC074274	SRI SAI KARUNA INDUSTRYS LIMITED	Director	04/05/2011	04/05/2011	-	Active	NO
39	U24233AP2011PLC077561	HONOUR LAB LIMITED	Director	21/11/2011	21/11/2011	-	Active	NO

Name :

Mr. Srinivasa Reddy Male

Designation :

Director

Address :

Plot No.933, Vivekananda Nagar Colony, Kukatpally, Hyderabad – 500 072, Andhra Pradesh, India

Date of Birth/Age :

02.02.1973

Date of Appointment :

11.07.2007

DIN No.:

00016085

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U45200AP1995PTC021532	VIPASSANA CONSTRUCTIONS PRIVATE LIMITED	Director	01/04/1997	01/04/1997	-	Active	NO
2	U24239AP1996PLC025371	GENX PHARMA LIMITED	Director	31/07/2008	28/10/1999	-	Active	NO
3	U24230AP1993PLC015582	HETERO DRUGS LIMITED	Director	29/09/2011	01/04/2001	-	Active	NO
4	U65993AP1993PTC015489	BANDIS INVESTMENTS PRIVATE LIMITED	Director	01/11/2001	01/11/2001	-	Active	NO
5	U24239AP1995PLC020625	SAKETHA DRUGS AND INTERMEDIATES LIMITED	Director	01/04/2002	01/04/2002	29/06/2011	Active	NO
6	U24239AP2002PLC040108	HETERO INTERNATIONAL LIMITED	Director	16/12/2002	16/12/2002	29/06/2011	Active	NO
7	U24239AP2004PLC043684	HETERO BIOTECH LIMITED	Director	19/07/2004	19/07/2004	01/12/2010	Active	NO
8	U85110AP1989PTC010293	HYDERABAD HOSPITALS PRIVATE LIMITED	Director	29/09/2004	29/09/2004	-	Active	NO
9	U24230AP2004PTC044710	XIVA HEALLTH CARE PRIVATE LIMITED	Director	29/11/2004	29/11/2004	-	Active	NO
10	U52520AP2006PLC049614	HETERO HEALTHCARE LIMITED	Director	24/03/2006	24/03/2006	-	Active	NO
11	U73100AP2007PTC052262	HETERO LIFE SCIENCES PRIVATE LIMITED	Director	05/01/2007	05/01/2007	-	Active	NO
12	U24231AP1998PLC029961	SYMED LABS LIMITED	Director	06/09/2007	11/07/2007	-	Active	NO
13	U72900AP2007PLC055111	HETERO INFORMATION TECHNOLOGIES LIMITED	Director	10/08/2007	10/08/2007	29/06/2011	Active	NO
14	U72200AP2007PLC055910	HETERO MED SOLUTIONS LIMITED	Director	15/10/2007	15/10/2007	-	Active	NO
15	U74999AP2007PLC056072	SRI SAI ASHIRWAAD LOGISTICS LIMITED	Director	25/10/2007	25/10/2007	08/03/2012	Active	NO
16	U24299AP2008PLC058020	HETERO BIO CHEMICALS LIMITED	Director	06/03/2008	06/03/2008	21/04/2011	Active	NO
17	U45200AP2006PLC049668	HETERO INFRASTRUCTURE SEZ LIMITED	Director	18/09/2008	01/08/2008	-	Active	NO
18	U24110AP1989PLC009723	HETERO LABS LIMITED	Director	25/09/2008	01/08/2008	-	Active	NO
19	U24230AP1984PTC004422	SVS DRUGS AND PHARMACEUTICALS PRIVATE LIMITED	Director	01/08/2008	01/08/2008	-	Active	NO
20	U24239AP1990PLC012119	CIREX PHARMACEUTICALS LIMITED	Director	26/08/2010	12/11/2009	-	Active	NO
21	U72200AP1997PTC027306	HETERO MARBLES PRIVATE LIMITED	Director	12/11/2009	12/11/2009	-	Active	NO
22	U21023AP2007PTC054088	CHEMI PACK (INDIA) PRIVATE LIMITED	Director	19/08/2010	19/11/2009	08/03/2012	Active	NO
23	U40100AP2010PLC071837	HETERO WIND POWER LIMITED	Director	23/12/2010	23/12/2010	-	Active	NO
24	U74900AP2008PLC058017	SHRI BHRAMARAMBIKAS INDUSTRYS LIMITED	Director	07/04/2011	07/04/2011	-	Active	NO
25	U24232AP2011PLC074274	SRI SAI KARUNA INDUSTRYS LIMITED	Director	04/05/2011	04/05/2011	-	Active	NO
26	U24233AP2011PLC077561	HONOUR LAB LIMITED	Director	21/11/2011	21/11/2011	-	Active	NO

Name :

Mr. Vamsikrishna Bandi

Designation :

Whole-time director

Address :

Plot No.389, Road No.22/B, Jubliee Hills Check Post, Hyderabad – 500 033, Andhra Pradesh, India

Date of Birth/Age :

31.07.1983

Date of Appointment :

10.04.2008

DIN No.:

01014619

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230AP2004PTC044710	XIVA HEALLTH CARE PRIVATE LIMITED	Director	29/11/2004	29/11/2004	-	Active	NO
2	U73100AP2007PTC052262	HETERO LIFE SCIENCES PRIVATE LIMITED	Director	05/01/2007	05/01/2007	-	Active	NO
3	U24239AP1996PLC025371	GENX PHARMA LIMITED	Director	26/09/2007	26/07/2007	-	Active	NO
4	U72200AP2007PLC055910	HETERO MED SOLUTIONS LIMITED	Director	15/10/2007	15/10/2007	-	Active	NO
5	U74999AP2007PLC056072	SRI SAI ASHIRWAAD LOGISTICS LIMITED	Director	25/10/2007	25/10/2007	-	Active	NO
6	U24299AP2008PLC058020	HETERO BIO CHEMICALS LIMITED	Director	06/03/2008	06/03/2008	-	Active	NO
7	U65993AP1993PTC015489	BANDIS INVESTMENTS PRIVATE LIMITED	Additional director	10/04/2008	10/04/2008	-	Active	NO
8	U24239AP1990PLC012119	CIREX PHARMACEUTICALS LIMITED	Director	29/09/2011	10/04/2008	-	Active	NO
9	U52520AP2006PLC049614	HETERO HEALTHCARE LIMITED	Director	25/09/2008	10/04/2008	-	Active	NO
10	U24230AP1993PLC015582	HETERO DRUGS LIMITED	Director	25/09/2008	10/04/2008	-	Active	NO
11	U24110AP1989PLC009723	HETERO LABS LIMITED	Whole-time director	01/05/2011	10/04/2008	-	Active	NO
12	U24231AP1998PLC029961	SYMED LABS LIMITED	Whole-time director	01/04/2009	10/04/2008	-	Active	NO
13	U24239AP1995PLC020625	SAKETHA DRUGS AND INTERMEDIATES LIMITED	Director	19/08/2010	12/11/2009	29/06/2011	Active	NO
14	U24239AP2004PLC043684	HETERO BIOTECH LIMITED	Director	19/08/2010	12/11/2009	29/06/2011	Active	NO
15	U72900AP2007PLC055111	HETERO INFORMATION TECHNOLOGIES LIMITED	Director	30/09/2010	12/11/2009	21/04/2011	Active	NO
16	U24230AP1984PTC004422	SVS DRUGS AND PHARMACEUTICALS PVT LTD	Director	19/08/2010	12/11/2009	-	Active	NO
17	U72200AP1997PTC027306	HETERO MARBLES PRIVATE LIMITED	Director	12/11/2009	12/11/2009	-	Active	NO
18	U21023AP2007PTC054088	CHEMI PACK (INDIA) PRIVATE LIMITED	Director	19/08/2010	19/11/2009	-	Active	NO
19	U45200AP2006PLC049668	HETERO INFRASTRUCTURE SEZ LIMITED	Director	23/09/2010	02/08/2010	-	Active	NO
20	U40100AP2010PLC071837	HETERO WIND POWER LIMITED	Director	23/12/2010	23/12/2010	-	Active	NO
21	U74900AP2008PLC058017	SHRI BHRAMARAMBIKAS INDUSTRYS LIMITED	Director	07/04/2011	07/04/2011	-	Active	NO
22	U24232AP2011PLC074274	SRI SAI KARUNA INDUSTRYS LIMITED	Director	04/05/2011	04/05/2011	-	Active	NO
23	U24233AP2011PLC077561	HONOUR LAB LIMITED	Director	21/11/2011	21/11/2011	-	Active	NO

Name :

Mr. Nandachary Mudumbi

Designation :

Additional director

Address :

8-5-222/ B/26(401), E 10,11 Vengal Rao Nagar, Erragadda, Hyderabad - 500038, Andhra Pradesh, India

Date of Birth/Age :

23.02.1956

Date of Appointment :

05.01.2012

DIN No.:

02714333

Other Directorship :

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Company/ LLP Status	Defaulting status
1	U21023AP2007PTC054088	CHEMI PACK (INDIA) PRIVATE LIMITED	Director	21/05/2007	21/05/2007	Active	NO
2	U40108AP2011PTC077815	SRI CHENNA KESAVA BIO ENERGY PRIVATE LIMITED	Director	05/12/2011	05/12/2011	Active	NO
3	U24231AP1998PLC029961	SYMED LABS LIMITED	Additional director	05/01/2012	05/01/2012	Active	NO

KEY EXECUTIVES

Name :	K.V.V. Rao
Designation :	Marketing Manager
Email ID:	kwrao@symedlabs.com

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

AS ON 29.09.2011

Names of Shareholders	No. of Shares
B. Partha Saradhi Reddy	120000
D. Mohan Rao	245000
A.V. Narasa Reddy	100
D. Vandana	110000
D. Spandana	110000
M. Krishna Sindhuri	92500
B. Kalavathi	40000
B Vamsi Krishna	32500
Bandi Investments Private Limited, India	180000
Total	930100

AS ON 29.09.2011

Equity Share Breakup	Percentage of Holding
Category
Bodies corporate	25.00
Directors or relatives of directors	69.00
Other top fifty shareholders	6.00
Total	100.00

BUSINESS DETAILS

Line of Business :

Manufactures of Bulk Drugs and Drug Intermediates

Products :

ITC Code	Product Descriptions
294110	Bulk Drug

v Balsalazide Disodium Dihydrate

v Bambuterol Hydrochloride

v Brimonidine Tartarate

v Carvedilol

v Fluconazole

v Itopride Hydrochloride

v Ketrolac Tromethamine

v Linezolid

v Racecadotril

v Sibutramine Hydrochloride

v Tamsulosine Hydrochloride

v Zaleplon

PRODUCTION STATUS AS ON (31.03.2011)

Class of Goods Manufacture	Bulk Drugs
Installed Capacity	2000 MT’S
Actual Production	1699

GENERAL INFORMATION

No. of Employees :

205 (In office 15 + In factory 190)

Bankers :

Andhra Bank, Specialised Corporate Finance Branch, 3^rd Floor, Padmaja Land Mark, Somajiguda, Hyderabad – 500 082, Andhra Pradesh, India

Facilities :

Secured Loan	As on 31.03.2011 (Rs. in Millions)	As on 31.03.2010 (Rs. in Millions)
Rupee term loans banks secured	10.064	21.366
Working capital loans banks secured	187.654	155.385
Total	197.718	176.751

Banking Relations :	--
Auditors :
Name :	M.V. Narayana Reddy and Company Chartered Accountants
Address :	504 Vijayasree Apartments, Behind Chermas, Ameerpet, Hyderabad - 500073 Andhra Pradesh, India
Income-tax PAN of auditor or auditor's firm :	AADFM4830F
Associates :	v Hetero Drugs Limited v CIN No.: U24230AP1993PLC015582 v Hetero Labs Limited v CIN No.: U24110AP1989PLC009723 v Cirex Pharmaceuticals Limited v CIN No.: U24239AP1990PLC012119 v Hetero Singapore Pte Limited v Invagen Pharmaceuticals Inc v Hetero FZCO v Hetsym Bio Chemicals Private Limited v CIN No.: U73100AP2008PTC058109 v Symed Chemicals Private Limited v CIN No.: U24110AP2008PTC058116
Subsidiaries :	Chemi Pack (India) Private Limited CIN No.: U21023AP2007PTC054088

CAPITAL STRUCTURE

AS ON 31.03.2011

Authorised Capital :

No. of Shares	Type	Value	Amount
2,000,000	Equity Shares	Rs. 10/- each	Rs. 20.000 Millions

Issued, Subscribed & Paid-up Capital :

No. of Shares	Type	Value	Amount
930,100	Equity Shares	Rs. 10/- each	Rs. 9.301 Millions

FINANCIAL DATA

[all figures are in Rupees Millions]

ABRIDGED BALANCE SHEET

SOURCES OF FUNDS		31.03.2011	31.03.2010	31.03.2009
SHAREHOLDERS FUNDS
1] Share Capital		9.301	9.301	9.301
2] Share Application Money		0.000	0.000	0.000
3] Reserves & Surplus		859.672	709.375	580.678
4] (Accumulated Losses)		0.000	0.000	0.000
NETWORTH		868.973	718.676	589.979
LOAN FUNDS
1] Secured Loans		197.718	176.751	170.166
2] Unsecured Loans		0.000	0.000	0.000
TOTAL BORROWING		197.718	176.751	170.166
DEFERRED TAX LIABILITIES		61.610	52.205	44.494
TOTAL		1128.301	947.632	804.639
APPLICATION OF FUNDS
FIXED ASSETS [Net Block]		602.528	499.550	451.342
Capital work-in-progress		0.000	0.000	0.000
INVESTMENT		32.643	31.578	31.497
DEFERREX TAX ASSETS		0.000	0.000	0.000
CURRENT ASSETS, LOANS & ADVANCES
	Inventories	269.936	211.010	158.027
	Sundry Debtors	352.470	293.724	282.910
	Cash & Bank Balances	7.390	11.248	5.646
	Other Current Assets	0.000	0.000	0.000
	Loans & Advances	132.341	87.433	79.676
Total Current Assets		762.137	603.415	526.259
Less : CURRENT LIABILITIES & PROVISIONS
	Sundry Creditors	197.655	113.402	172.632
	Other Current Liabilities	0.000	0.000	0.000
	Provisions	71.352	73.509	31.827
Total Current Liabilities		269.007	186.911	204.459
Net Current Assets		493.130	416.504	321.800
MISCELLANEOUS EXPENSES		0.000	0.000	0.000
TOTAL		1128.301	947.632	804.639

PROFIT & LOSS ACCOUNT

	PARTICULARS		31.03.2011	31.03.2010	31.03.2009
	SALES
		Income	1118.628	974.930	885.096
		Other Income	4.077	0.053	4.679
		TOTAL (A)	1122.705	974.983	889.775
Less	EXPENSES
		Consumption materials changes inventories	580.014	470.308
		Manufacturing service costs	98.160	108.207
		Employee related expenses	50.997	49.445
		Administrative selling other expenses	64.300	67.721
		Research development expenditure	49.666	13.665
		TOTAL (B)	843.137	709.346	652.625
Less	PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C)		279.568	265.637	237.150
Less	FINANCIAL EXPENSES (D)		24.434	22.121	17.708
	PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)		255.134	243.516	219.442
Less/ Add	DEPRECIATION/ AMORTISATION (F)		24.082	22.085	16.696
	PROFIT BEFORE TAX (E-F) (G)		231.052	221.431	202.746
Less	TAX (H)		59.064	70.970	53.289
	PROFIT AFTER TAX (G-H) (I)		171.988	150.461	149.457
Add	PREVIOUS YEARS’ BALANCE BROUGHT FORWARD		346.399	262.701	158.244
Less	APPROPRIATIONS
		Transfer to General Reserve	88.023	45.000	45.000
		Interim Dividend	18.602	18.602	0.000
		Tax on Dividend	3.090	3.161	0.000
	BALANCE CARRIED TO THE B/S		408.672	346.399	262.701
	EARNINGS IN FOREIGN CURRENCY
		Export Earnings	250.333	242.771	282.031
	TOTAL EARNINGS		250.333	242.771	282.031
	IMPORTS
		Raw Materials	168.759	153.196	104.079
		Capital Goods	8.415	2.421	10.989
		Foreign Travel	2.639	2.822	1.964
		Consultancy Charges	3.809	11.703	0.000
	TOTAL IMPORTS		183.622	170.142	117.032
	Earnings Per Share (Rs.)		184.91	161.77	160.69

KEY RATIOS

PARTICULARS		31.03.2011	31.03.2010	31.03.2009
PAT / Total Income	(%)	15.32	15.43	16.80
Net Profit Margin (PBT/Sales)	(%)	20.65	22.71	22.91
Return on Total Assets (PBT/Total Assets}	(%)	16.93	20.08	20.74
Return on Investment (ROI) (PBT/Networth)		0.27	0.31	0.34
Debt Equity Ratio (Total Liability/Networth)		0.54	1.09	1.18
Current Ratio (Current Asset/Current Liability)		2.83	3.23	2.57

LOCAL AGENCY FURTHER INFORMATION

Check List by Info Agents	Available in Report (Yes / No)
1. Year of Establishment	Yes
2. Locality of the firm	Yes
3. Constructions of the firm	Yes
4. Premises details	No
5. Type of Business	Yes
6. Line of Business	Yes
7. Promoter’s background	Yes
8. No. of Employees	Yes
9. Name of person contacted	No
10. Designation of contact person	No
11. Turnover of firm for last three years	Yes
12. Profitability for last three years	Yes
13. Reasons for variation <> 20%	--
14. Estimation for coming financial year	No
15. Capital in the business	Yes
16. Details of sister concerns	Yes
17. Major suppliers	No
18. Major customers	No
19. Payments terms	No
20. Export / Import details	No
21. Market information	--
22. Litigations that the firm / promoter involved	--
23. Banking Details	Yes
24. Banking facility details	Yes
25. Conduct of the banking account	--
26. Buyer visit details	--
27. Financials, if provided	Yes
28. Incorporation details, if applicable	Yes
29. Last accounts filed at ROC	Yes
30. Major Shareholders, if available	Yes

BANKERS CHARGES REPORT AS PER REGISTRY

Corporate identity number of the company	U24231AP1998PLC029961
Name of the company	SYMED LABS LIMITED
Address of the registered office or of the principal place of business in India of the company	8-3-166/6, 2^nd Floor Sree Arcade, Erragadda, Hyderabad – 500 018, Andhra Pradesh, India
This form is for	Modification of charge
Charge identification number of the modified	10063091
Type of charge	Book Debts Movable Property Floating Charge Others (Hypothecation of raw materials, finished goods,WIP)
Particular of charge holder	Andhra Bank, Specialised Corporate Finance Branch, 3^rd Floor, Padmaja Land Mark, Somajiguda, Hyderabad – 500 082, Andhra Pradesh, India Email ID: bmhydm1006@andhrabank.co.in
Nature of description of the instrument creating or modifying the charge	Demand Promissory notes dated 30th December, 2011 Composite Agreement dated 30th December, 2011 General form of Guarantee and other documents dated 30th December 2011
Date of instrument Creating the charge	30.12.2011
Amount secured by the charge	Rs. 984.000 Millions
Brief particulars of the principal terms an conditions and extent and operation of the charge	Rate of Interest PC-Base rate +3.75% i.e. 14.50%, Term Loan-14.75%, Corporate Loan 14.75% Terms of Repayment Working Capital-as agreed between the Banker and Company Term-Loan-48 installments with initial moratorium period of 1 year Corporate Loan-12 Quarterly Installments starting from June, 2012 Margin Stock and book-debts-25%, Term Loan- 25% Extent and Operation of the charge First Charge on fixed assets and current assets Others Nil
Short particulars of the property charged	All fixed assets of the company wherever located and all current assets laid at all units of the company and book-debts not older than six months
Date of latest modification prior to the present modification	15.12.2010
Particulars of the present modification	Rs in Millions Particulars Existing Modified O.C.C 150.000 360.000 F.L.C/I.L.C 100.000 300.000 B.G 10.000 24.000 Corporate Loan ----- 160.000 Term Loan ----- 140.000 ------------ -------------- 260.000 984.000 ====== =======

CONTINGENT LIABILITIES

Contingent Liabilities not provided for

(Rs. in Millions)

Particulars	31.03.2011	31.03.2010
Guarantees given by Banks	1.375	8.400
Unexpired Letter of Credit	98.878	71.630
Corporate Guarantee on behalf of Subsidiary Company	56.100	56.100

FIXED ASSETS:

v Land

v Building

v Building – Staff Quarters

v Machinery

v Electrical Equipment

v Furniture

v Computers

v Vehicles

v R and D Equipment

v R and D Building

v Office Equipment

v Patents

CMT REPORT (Corruption, Money Laundering & Terrorism]

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

1] INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

2] Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

3] Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

4] Record on Financial Crime :

Charges or conviction registered against subject: None

5] Records on Violation of Anti-Corruption Laws :

Charges or investigation registered against subject: None

6] Records on Int’l Anti-Money Laundering Laws/Standards :

Charges or investigation registered against subject: None

7] Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

8] Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

9] Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

10] Press Report :

No press reports / filings exists on the subject.

CORPORATE GOVERNANCE

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

CONTRAVENTION

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs. 55.81
UK Pound	1	Rs. 86.53
Euro	1	Rs. 68.58

INFORMATION DETAILS

Report Prepared by :

BVA

SCORE & RATING EXPLANATIONS

SCORE FACTORS	RANGE	POINTS
HISTORY	1~10	4
PAID-UP CAPITAL	1~10	5
OPERATING SCALE	1~10	7
FINANCIAL CONDITION
--BUSINESS SCALE	1~10	7
--PROFITABILIRY	1~10	6
--LIQUIDITY	1~10	6
--LEVERAGE	1~10	5
--RESERVES	1~10	7
--CREDIT LINES	1~10	6
--MARGINS	-5~5	-
DEMERIT POINTS
--BANK CHARGES	YES/NO	YES
--LITIGATION	YES/NO	NO
--OTHER ADVERSE INFORMATION	YES/NO	NO
MERIT POINTS
--SOLE DISTRIBUTORSHIP	YES/NO	NO
--EXPORT ACTIVITIES	YES/NO	NO
--AFFILIATION	YES/NO	YES
--LISTED	YES/NO	NO
--OTHER MERIT FACTORS	YES/NO	YES
TOTAL		53

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.